EUCTR2005-000949-11-IT进行中（未招募）不适用
A Phase 3, Randomized, Double-blind Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Advanced, Malignant Pleural Mesothelioma Refractory to Systemic Chemotherapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 660
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory MyopathyPolymyositis, Dermatomyositis, Autoimmune Necrotizing Myopathy, Overlap Myositis, Juvenile Myositis Above the Age of 18JPRN-jRCT2080223614Bristol-Myers Squibb K.K.150
进行中（未招募）
1 期
A Phase 3 trial to evaluate the effectiveness and safety of Abatacept SC alongside standard treatment in comparison to standard treatment alone in improving disease activity in adults with active idiopathic inflammatory myopathy, a group of chronic autoimmune inflammatory diseases that affect skeletal muscle.Idiopathic Inflammatory Myopathy (IIMeg, Dermatomyositis [DM], Polymyositis [PM], autoimmune necrotizing myopathy)MedDRA version: 20.0Level: LLTClassification code 10042753Term: Symptomatic inflammatory myopathySystem Organ Class: 100000004859EUCTR2016-002269-77-SEBristol-Myers Squibb International Corporation148
进行中（未招募）
1 期
A Phase 3 trial to evaluate the effectiveness and safety of Abatacept SC alongside standard treatment in comparison to standard treatment alone in improving disease activity in adults with active idiopathic inflammatory myopathy, a group of chronic autoimmune inflammatory diseases that affect skeletal muscle.Idiopathic Inflammatory Myopathy (IIMeg, Dermatomyositis [DM], Polymyositis [PM], autoimmune necrotizing myopathy)MedDRA version: 20.0Level: LLTClassification code 10042753Term: Symptomatic inflammatory myopathySystem Organ Class: 100000004859EUCTR2016-002269-77-DEBristol-Myers Squibb International Corporation150
进行中（未招募）
1 期
A Phase 3, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC with Standard Treatment Compared to Standard Treatment Alone in Improving Disease Activity in Adults with Active Idiopathic Inflammatory Myopathy (IIM)EUCTR2016-002269-77-FRBristol-Myers Squibb International Corporation150
进行中（未招募）
1 期
A Phase 3 trial to evaluate the effectiveness and safety of Abatacept SC alongside standard treatment in comparison to standard treatment alone in improving disease activity in adults with active idiopathic inflammatory myopathy, a group of chronic autoimmune inflammatory diseases that affect skeletal muscle.Idiopathic Inflammatory Myopathy (IIMeg, Dermatomyositis [DM], Polymyositis [PM], autoimmune necrotizing myopathy)MedDRA version: 21.0Level: LLTClassification code 10042753Term: Symptomatic inflammatory myopathySystem Organ Class: 100000004859EUCTR2016-002269-77-ITBRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATIO150